EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating ...
With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2% Global Phase 3 MANEUVER study demonstrated ongoing improvements in key secondary ...
github-actions changed the title azure ai foundry connections should be passed as connection names rather than ID Python: azure ai foundry connections should be passed as connection names rather than ...
Hello guys, I am working on creating a Monitoring using Azure ML mainly for checking the Data Quality signal (Quality of the baseline and production data) and Data Drift signal (Change in distribution ...